AtroventHFA (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Atrovent drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | ipratropium bromide |
| SUBSTANCE NAME: | IPRATROPIUM BROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | AEROSOL, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-05-01 |
| END MARKETING DATE: | 0000-00-00 |
Atrovent HFA HUMAN PRESCRIPTION DRUG Details:
| Item Description | Atrovent HFA from Boehringer Ingelheim Pharmaceuticals Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 17(ug/1) |
| START MARKETING DATE: | 2005-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0087_e22f2968-efa5-3e83-a678-e79962ac343a |
| PRODUCT NDC: | 0597-0087 |
| APPLICATION NUMBER: | NDA021527 |
Other IPRATROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers:
